Zhonghong Pulin Medical Products Co., Ltd.
中红医疗
300981
Shenzhen Stock Exchange
Company Profile
1、Product Advantage After years of experimental exploration, R&D innovation and technology accumulation, the company has formed a scientific and effective full-process production system and quality control system in the production process of various products, which is designed in strict accordance with domestic or international standards. It can ensure the quality of the products from the technical, production and management aspects, and realize the real-time control of the whole process of the product line, covering all the links of research and development, design, procurement, manufacturing and delivery. The company's advanced technology, equipment and process advantages ensure high quality delivery and create a quality company reputation. 2、Innovation Advantage The company has long been taking science and technology as the guide, attaching importance to the investment in product and technology innovation, working closely with relevant scientific research institutions and colleges and universities, and receiving recognition and support from government departments at various levels. The company focuses on the enhancement of the R & D team, through external recruitment and integration of the newly acquired company's R & D team, the company's R & D strength has been significantly strengthened, R & D team in Beijing, Shanghai, Shenzhen, Hainan, Jiangxi, Guilin and other places, to create an innovative R & D platform, which can effectively give full play to the advantages of the resources of the local advantages and talent advantages, and has laid a solid foundation for the realization of the company's innovation strategy. The company was successfully selected to create a list of world-class specialties and new demonstration enterprises, the company and the research institute and the North China University of Science and Technology jointly constructed high-performance gloves with rubber and plastic materials preparation technology in Hebei Province Engineering Research Center was selected as the list of provincial engineering research centers in preparation for the construction plan, the company will seize the above favorable opportunity to increase in the market outlook, high technology content, user demand, profitability and sufficient space in the field of layout, to improve the level of research and development and results conversion efficiency, to further enhance the company's innovation strategy. The company will seize the above favorable opportunity to increase the layout in areas with good market prospects, high technology content, large user demand and sufficient profitability, improve the level of research and development and the efficiency of transformation of achievements, and further anchor and build up the advantages in research and development innovation. 3、Channel Advantage After years of development, the company has been deeply cultivating in the field of disposable health protection gloves for many years, and has experienced sales personnel and channel resources. The relevant products of the company have successively passed the U.S. FDA certification, the European Union's CE certification, ISO9001 international quality system certification, ISO13485 international quality system certification, etc., and are exported to more than 80 countries and regions around the world. At present, the company is rated as V-class customer by China Export Credit Insurance Corporation. The company and its subsidiaries Kelun Medical Devices, Hengbao Health and Meidrina have strong complementary product channels, and the integration and optimization of relevant resources can achieve efficient synergy. At present, the company's marketing pattern of "one center, three pivots and eight regions" and the constantly enriched online promotion methods can provide a strong channel foundation for the company's future expansion of new and old business in the relevant regions and platforms. 4、Capital Advantage At present, the company has abundant cash flow, low gearing ratio, convenient capital market financing platform and generous bank credit line, which provides a wide range of financing channels for the company's direct financing and indirect financing. The company's financial cost is relatively low, the overall anti-risk, cross-cycle ability is stronger, for the company's new business layout, investment and mergers and acquisitions, R & D investment, product core competitiveness consolidation and enhancement of the company to provide a strong financial guarantee. 5、Talent Advantage The company's main executive team in the medical industry production and sales, R & D innovation, investment and mergers and acquisitions and other aspects of the accumulation of deep experience, for the company's existing products to reduce costs and increase efficiency, the development of new race track and post-investment integration has laid a solid foundation. The company continuously optimizes the knowledge structure, ability structure and age structure of the staff, and the construction of talent echelon is effective, which constitutes an important competitive advantage for the development of the company.
Full description
Since its establishment, the company has been deeply involved in the medical device field for over 20 years, focusing on the research, development, production, and sales of high-quality disposable health protection products, sterile medical devices, and comprehensive life support solutions. The company has three major divisions: Health Protection, Safe Infusion, and Innovation Incubation. The Health Protection division mainly produces a full range of disposable protective gloves including nitrile, PVC, natural latex, polyisoprene, and radiation-proof types, as well as a series of contraceptive products such as natural latex, polyurethane, and polyisoprene condoms. The Safe Infusion division primarily handles infusion sets, syringes, blood collection tubes, and indwelling needles. The Innovation Incubation division focuses on infusion pumps, injection pumps, enteral nutrition pumps, and infusion information collection systems, as well as products and services like non-invasive temperature monitoring and information management systems in operating rooms. 1. Health Protection Division The Health Protection Division is primarily engaged in the R&D, production, and sales of high-quality gloves including nitrile gloves, PVC gloves, natural latex gloves, radiation shielding gloves, and polyisoprene gloves, as well as condoms. The company is one of the earliest domestic producers and sellers of PVC and nitrile gloves. Through years of operation, independent innovation, and horizontal mergers and acquisitions, it has established leading technological barriers and innovative capabilities in the industry. It can develop almost all types of disposable health protection gloves to meet customers' diverse requirements in terms of glove performance, specifications, models, and colors. It has certain technological and scale advantages and is well-known in the industry, placing it in a leading position. The company can mass-produce over 100 different types of condom products, essentially meeting various needs for different scenarios. In 2023, the company obtained a medical device registration certificate for polyisoprene male condoms from the Guangxi Zhuang Autonomous Region Food and Drug Administration, fundamentally achieving the production and sales of a full range of condom products. At the same time, the company is actively building the "Zhonghong" high-end condom brand, has developed different series of products including "Zhonghong 001 Series," "Zhonghong Comfort Skin Series," and "Zhonghong Comfort Skin Series - Fragrance Edition," and successfully held a new product launch event for the "Zhonghong" brand. 2. Safe Infusion Division The Safe Infusion Division mainly focuses on products related to infusion devices, such as precision infusion sets, indwelling needles, standard infusion sets, standard syringes, and blood collection tubes. These products have strong synergies with the company's original main business of health protection products. They can empower each other through R&D and sales, facilitating collaborative development. The Safe Infusion Division has helped the company expand its industry track, extending the product line from nitrile, PVC, and other health protection areas to the safe infusion field. This expansion not only increases the company's revenue but also effectively mitigates the risk of market fluctuations, addressing the vulnerability of relying solely on single-industry products. 3. Innovation Incubation Division In 2023, the company acquired 70% of the shares of Medtronic in cash. Medtronic's main business includes the R&D, production, and sales of devices such as infusion pumps, injection pumps, and infusion information collection systems. The company and Medtronic have highly complementary supply chain resources, domestic and international channels, technology R&D, and high-end talent, which can effectively leverage resource integration advantages. Additionally, the company has established a long-term, comprehensive strategic partnership with Mac Technology, signing an agency distribution agreement that authorizes the company to distribute products such as wireless temperature sensors and wireless continuous monitoring sensor probes on its behalf. Mac Technology and its subsidiary Medtronic can synergize their product lines to help the company expand its life support solutions product line, aiming to position the company as a leading and globally promising provider of life support solutions in China.